Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Biopharma (CBIO) Shares Issued (2016 - 2025)

Crescent Biopharma (CBIO) has disclosed Shares Issued for 10 consecutive years, with $102.0 as the latest value for Q2 2025.

  • On a quarterly basis, Shares Issued changed N/A to $102.0 in Q2 2025 year-over-year; TTM through Dec 2025 was $5000.0, a N/A change, with the full-year FY2025 number at $5000.0, down 7.37% from a year prior.
  • Shares Issued was $102.0 for Q2 2025 at Crescent Biopharma, down from $4898.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $28.7 million in Q2 2023 to a low of -$28.6 million in Q3 2023.
  • A 4-year average of $3.9 million and a median of $19333.0 in 2023 define the central range for Shares Issued.
  • Biggest YoY gain for Shares Issued was 188.09% in 2021; the steepest drop was 309.76% in 2021.
  • Crescent Biopharma's Shares Issued stood at $10.7 million in 2021, then soared by 167.85% to $28.6 million in 2023, then tumbled by 99.98% to $4898.0 in 2024, then plummeted by 97.92% to $102.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIO's Shares Issued are $102.0 (Q2 2025), $4898.0 (Q1 2024), and $28.6 million (Q4 2023).